Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 2
2009 1
2013 2
2015 1
2017 6
2018 3
2019 1
2020 4
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for levetiracetam neuro pharm
Your search for levetiracetam-neuropharm retrieved no results
Levetiracetam for managing neurologic and psychiatric disorders.
Farooq MU, Bhatt A, Majid A, Gupta R, Khasnis A, Kassab MY. Farooq MU, et al. Am J Health Syst Pharm. 2009 Mar 15;66(6):541-61. doi: 10.2146/ajhp070607. Am J Health Syst Pharm. 2009. PMID: 19265183 Review.
PURPOSE: The role of levetiracetam in different epileptic, nonepileptic, neurologic, and psychiatric disorders is discussed. ...CONCLUSION: Levetiracetam is an effective AED with potential benefits in other neurologic and psychiatric disorders. ...
PURPOSE: The role of levetiracetam in different epileptic, nonepileptic, neurologic, and psychiatric disorders is discussed. ...CONCL …
Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies.
Ferlazzo E, Trenite DK, Haan GJ, Felix Nitschke F, Ahonen S, Gasparini S, Minassian BA. Ferlazzo E, et al. Curr Pharm Des. 2017;23(37):5662-5666. doi: 10.2174/1381612823666170809114654. Curr Pharm Des. 2017. PMID: 28799509 Free PMC article. Review.
Valproic acid is the drug of choice, except for PMEs due to mitochondrial diseases. Levetiracetam and clonazepam should be considered as the first add-on treatment. ...
Valproic acid is the drug of choice, except for PMEs due to mitochondrial diseases. Levetiracetam and clonazepam should be considered …
Adaptive Dosage Strategy of Levetiracetam in Chinese Epileptic Patients: Focus on Pregnant Women.
Duan Y, Yang X, Zhang M, Qi X, Jin Y, Wang Z, Chen L. Duan Y, et al. J Pharm Sci. 2024 May;113(5):1385-1394. doi: 10.1016/j.xphs.2023.12.025. Epub 2024 Jan 2. J Pharm Sci. 2024. PMID: 38176454
A total of 322 levetiracetam plasma concentrations from 238 patients with epilepsy were included, including 216 women with epilepsy (20.83% of whom were pregnant). ...Pregnancy and body weight were found to be significant covariates of CL/F of levetiracetam. The rec …
A total of 322 levetiracetam plasma concentrations from 238 patients with epilepsy were included, including 216 women with epilepsy ( …
Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management.
Vecht C, Royer-Perron L, Houillier C, Huberfeld G. Vecht C, et al. Curr Pharm Des. 2017;23(42):6464-6487. doi: 10.2174/1381612823666171027130003. Curr Pharm Des. 2017. PMID: 29076421 Review.
Both can be combined with levetiracetam in case monotherapy is inactive or produces side-effects. ...On seizure prophylaxis, there is some evidence for its application in the peri-operative period. The most prevalent side-effects of AEDs in neuro-oncology are cognit …
Both can be combined with levetiracetam in case monotherapy is inactive or produces side-effects. ...On seizure prophylaxis, there is …
Evaluation of Safety Outcomes of Undiluted Levetiracetam Intravenous Push Compared to Intravenous Piggyback.
Shim A, Radparvar S, Davis N, Kaplan A, Kantaris K, Devlin A, Liang J, Ciummo F. Shim A, et al. J Pharm Pract. 2024 Jun;37(3):722-727. doi: 10.1177/08971900231176457. Epub 2023 May 26. J Pharm Pract. 2024. PMID: 37231709
Background: Breakthrough seizures and status epilepticus require urgent management. Administration of intravenous push (IVP) levetiracetam has been demonstrated to be safe as compared to intravenous piggyback (IVPB). ...The objective of this study was to observe safety of …
Background: Breakthrough seizures and status epilepticus require urgent management. Administration of intravenous push (IVP) levetiraceta …
Use of antiepileptics for seizure prophylaxis after traumatic brain injury.
Torbic H, Forni AA, Anger KE, Degrado JR, Greenwood BC. Torbic H, et al. Am J Health Syst Pharm. 2013 May 1;70(9):759-66. doi: 10.2146/ajhp120203. Am J Health Syst Pharm. 2013. PMID: 23592358 Review.
According to the latest guidelines issued by the Brain Trauma Foundation and the American Academy of Neurology (AAN) for the management of severe TBI, PTS prophylaxis is recommended only during the first seven days after TBI. ...However, levetiracetam has been assoc …
According to the latest guidelines issued by the Brain Trauma Foundation and the American Academy of Neurology (AAN) for the manageme …
Rectal use of levetiracetam: best practice report for a stepwise approach for sustainable off-label decision making and treatment.
Rémi C, Hermann A, Krull E, Ockert-Schön F, Rémi J. Rémi C, et al. Int J Clin Pharm. 2023 Jun;45(3):774-780. doi: 10.1007/s11096-023-01539-3. Epub 2023 Feb 8. Int J Clin Pharm. 2023. PMID: 36753020 Free PMC article.
A decision and documentation aid for off-label use was developed to support practitioners in clinical practice off-label use. Using the example of the rectal administration of levetiracetam in three patient cases, the utilisation and benefits of the decision and documentat …
A decision and documentation aid for off-label use was developed to support practitioners in clinical practice off-label use. Using the exam …
Levetiracetam induced psoriasiform drug eruption: a rare case report.
Gencler OS, Gencler B, Altunel CT, Arslan N. Gencler OS, et al. Saudi Pharm J. 2015 Nov;23(6):720-2. doi: 10.1016/j.jsps.2015.02.010. Epub 2015 Feb 27. Saudi Pharm J. 2015. PMID: 26702269 Free PMC article.
Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. Here we report the case of psoriasiform drug eruption in a patient with newly diagnosed epilepsy who had been treated with levetiracetam …
Levetiracetam (LEV) is an established second generation anti-epileptic drug and LEV associated severe cutaneous reactions are rare. H …
Analytical and clinical validation of an LC-MS/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots.
Besten-Bertholee DD, Wegner I, Touw DJ, Ter Horst PGJ. Besten-Bertholee DD, et al. Eur J Hosp Pharm. 2023 Mar 9:ejhpharm-2022-003589. doi: 10.1136/ejhpharm-2022-003589. Online ahead of print. Eur J Hosp Pharm. 2023. PMID: 36894298
For levetiracetam, concentrations were higher in plasma samples than in DBS (slope 1.21), implying a conversion factor is needed. ...CONCLUSIONS: The method was successfully validated and will be used for therapeutic drug monitoring in patients using carbamazepine, lamotri …
For levetiracetam, concentrations were higher in plasma samples than in DBS (slope 1.21), implying a conversion factor is needed. ... …
A Comparative Study on the Efficacy of Levetiracetam and Carbamazepine in the Treatment of Rolandic Seizures in Children: An Open-Label Randomized Controlled Trial.
Ahadi P, Nasiri J, Ghazavi MR, Mosavian T, Mansouri V. Ahadi P, et al. J Res Pharm Pract. 2020 Jun 26;9(2):68-72. doi: 10.4103/jrpp.JRPP_20_53. eCollection 2020 Apr-Jun. J Res Pharm Pract. 2020. PMID: 33102380 Free PMC article.
After a follow-up for 6 months, one out of 47 (2.1%) patients using levetiracetam showed intolerance, resulting in changing the medication. ...CONCLUSION: This study showed encouraging results for using levetiracetam, with acceptable results and fewer side effects f …
After a follow-up for 6 months, one out of 47 (2.1%) patients using levetiracetam showed intolerance, resulting in changing the medic …
26 results